What is the current stock price of Invitae Corporation (NVTA)?

As of the latest market data, Invitae Corporation (NVTA) is trading at $0.02. The stock has seen a loss of -35.59% today.

Does Invitae Corporation (NVTA) pay a dividend?

Based on current data, Invitae Corporation does not have a confirmed active dividend policy.

What is the market cap of Invitae Corporation?

The current market capitalization of Invitae Corporation (NVTA) is approximately unavailable.

NVTA

Invitae Corporation·Healthcare

0.02

35.593%(−0.01)

Market Closed

Last Updated: — ET

52W L: $0.0152W H: $2.34

Company Profile

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

1,700

IPO Date

2015-02-12

Beta

1.59

Websitewww.invitae.com↗